Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 2Small Cell Lung Carcinoma 1Pinealoma 1Pain 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Memory Disorders 1Medulloblastoma 1Lung Neoplasms 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Fatigue 1Ependymoma 1Depression 1Delirium 1Craniopharyngioma 1Cognitive Dysfunction 1Choroid Plexus Neoplasms 1Cancer Pain 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 8Zoledronic Acid 7Fentanyl 7nabiximols 6Morphine 6Ibandronic Acid 6Ketamine 5Hydromorphone 5Analgesia 5Acetaminophen 5Tapentadol 4Oxycodone 4Acupuncture Therapy 4alvimopan 3Ropivacaine 3Prednisone 3Lidocaine 3cabozantinib 2Tetrodotoxin 2Mitoxantrone 2Gabapentin 2Duloxetine Hydrochloride 2Docetaxel 2Calcium 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2strontium chloride 1resiniferatoxin 1oxycodone-acetaminophen 1oxycodone naloxone combination 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pain × Donepezil × Clear all
NCT00688376 2022-01-05

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Eisai Inc.

Phase 3 Completed
72 enrolled 10 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡